Vietnam: Approval of Vaccine Certificates from 72 Countries and Territories

Key Points  

  • Vietnam government approves vaccine certificates from 72 countries and territories 


The government of Vietnam has temporarily recognized COVID-19 vaccine certificates from 72 countries and territories beginning Oct. 21, 2021. Eligible travelers will be required to undergo a 7-day quarantine and present proof of vaccination upon entrance. For a list of countries and territories with approved vaccine certificates click here.  

What are the Changes?  

Vietnam suspended the entrance of foreign nationals in March 2020. This new change will allow fully vaccinated travelers from eligible countries and territories to enter Vietnam and undergo less strict entrance and quarantine restrictions.  

Looking Ahead 

Continue to check Vietnam’s government website and Envoy’s website for additional information and updates.  


Content in this publication is for informational purposes only and not intended as legal advice, nor should it be relied on as such. For additional information on the issues discussed, consult an attorney at one of the two U.S. Law Firms working with the Envoy Platform or another qualified professional. On non-U.S. immigration issues, consult an Envoy global immigration service provider or another qualified representative. 

Previous Article
White House Officially Releases New COVID-19 Travel Guidance for Travelers Entering U.S.
White House Officially Releases New COVID-19 Travel Guidance for Travelers Entering U.S.

The U.S. government has released official guidance for travelers to safely resume global travel during the ...

Next Article
Guyana: More Vaccines Accepted From International Travelers

Guyana is accepting vaccines approved by US FDA and the World Health Organization as well as some vaccines ...


Stay up-to-date on COVID-19's impact on immigration

By submitting this form, you will receive the requested information, as well as occasional related business insights from Envoy. You can unsubscribe at any time. For details, view our Privacy Policy.
Thank you for subscribing!
Error - something went wrong!